Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting Farhat Nasim5 May 2019 10:00 AM ISTEmgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Medical Dialogues Bureau1 May 2019 12:07 PM ISTPfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study Farhat Nasim20 April 2019 10:00 AM ISTThe drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
Cigna caps insulin prices at $25 for 30 days Medical Dialogues Bureau4 April 2019 9:00 AM ISTCigna, which bought pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25...
Unichem Labs gets USFDA approval for Tadalafil Tablets Farhat Nasim30 March 2019 9:30 AM ISTTadalafil tablets are a generic version of Eli Lilly's Cialis tablets. The drug is indicated for the treatment of erectile dysfunction (ED), the signs...
Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes Farhat Nasim24 March 2019 9:45 AM ISTThe decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin,...
Pfizer quarterly profit in line, touts pipeline of future products Medical Dialogues Bureau31 Jan 2019 9:05 AM ISTOn a call with analysts, new Chief Executive Albert Bourla said Pfizer had "the best pipeline in our history," and predicted that the company would...
Eli Lilly to acquire Loxo Oncology for $8 billion Medical Dialogues Bureau8 Jan 2019 12:09 PM ISTWashington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin Medical Dialogues Bureau17 Oct 2018 3:16 PM ISTUS : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
AstraZeneca plots China robot offensive to counter price cuts Medical Dialogues Bureau21 Sept 2018 9:02 AM ISTWUXI, China/LONDON: With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 4:50 PM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
